Search Within

Shakeel Modak

Formats
  1. Journal Article (136)
  2. Meeting Abstract (109)
  3. Book Section (3)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Neuroblastoma Service (250)
  2. Pediatrics, Department of (250)
  3. GSK Faculty (183)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (181)
  5. Tow Center for Developmental Oncology (TCDO) (177)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (171)

More Groups

People
  1. Nai-Kong Cheung (169)
  2. Brian Kushner (155)
  3. Kim Kramer (105)
  4. Ellen Basu (77)
  5. Stephen Roberts (68)
  6. Michael La Quaglia (57)

More People

Years
  1. 2025 (3)
  2. 2024 (11)
  3. 2023 (15)
  4. 2022 (13)
  5. 2021 (12)
  6. 2020 (13)

More Years

Publications
  1. Pediatric Blood and Cancer (69)
  2. Journal of Clinical Oncology (35)
  3. International Journal of Radiation Oncology, Biology, Physics (15)
  4. Neuro-Oncology (11)
  5. Journal of Nuclear Medicine (9)
  6. Journal of Pediatric Hematology/Oncology (8)

More Publications

Publishers
  1. Wiley Periodicals, Inc (69)
  2. American Society of Clinical Oncology (36)
  3. Elsevier Inc. (23)
  4. American Association for Cancer Research (17)
  5. Lippincott Williams & Wilkins (12)
  6. Oxford University Press (11)

More Publishers

Results (250)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I study of the combination of anti-GD2 antibody 3F8 and barley-derived (1→3,1→4)-ß-D-glucan for patients with resistant neuroblastoma
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Kramer, K.; Vickers, A.; Cheung, N.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Anti-GD2 monoclonal antibody 3F8 plus granulocyte-macrophage colony-stimulating factor (GM-CSF) for primary refractory neuroblastoma (NB) in bone marrow (BM)
    Meeting Abstract

    Kushner, B. H.; Kramer, K.; Modak, S.; Cheung, N. V.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Metastatic neuroblastoma (NB) to the central nervous system (CNS): Improved outcome with combined modality including 131-I-8H9 or 131-I-3F8 radioimmunotherapy (RIT) delivered through the cerebrospinal fluid (CSF)
    Meeting Abstract

    Kramer, K.; Modak, S.; Kushner, B. H.; Souweidane, M.; Wolden, S.; Humm, J.; Zanzonico, P.; Smith-Jones, P.; Larson, S.; Cheung, N.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I study of the combination of anti-GD2 antibody 3F8 and barley-derived beta glucan for resistant neuroblastoma
    Meeting Abstract

    Modak, S.; Kushner, B.; Kramer, K.; Vickers, A.; Cheung, N. K.
    Pediatric Blood and Cancer (2007)

    Fulltext@MSK | Save
  • Disialoganglioside directed immunotherapy of neuroblastoma
    Journal Article

    Modak, S.; Cheung, N. K. V.
    Cancer Investigation (2007)

    Fulltext@MSK | Save
  • High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: Broad implications for immunotherapy
    Journal Article

    Kushner, B. H.; Cheung, I. Y.; Kramer, K.; Modak, S.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2007)

    Fulltext@MSK | Save
  • Whole-body clearance kinetics and external dosimetry of 131I-3F8 monoclonal antibody for radioimmunotherapy of neuroblastoma
    Journal Article

    Dauer, L. T.; St. Germain, J.; Williamson, M. J.; Zanzonico, P.; Modak, S.; Cheung, N. K.; Divgi, C.
    Health Physics (2007)

    Fulltext@MSK | Save
  • Targeting of vascular endothelial growth factor (VEGF) synergizes with I-131-3F8 in radioinummotherapy of human neuroblastoma (NB)
    Meeting Abstract

    Modak, S.; Chung, J.; Cheung, N. K. V.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Topotecan, thiotepa, and carboplatin for neuroblastoma: Failure to prevent relapse in the central nervous system
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Kernan, N. A.; Reich, L. M.; Danis, K.; Cheung, N. K. V.
    Bone Marrow Transplantation (2006)

    Fulltext@MSK | Save
  • Irinotecan plus temozolomide for relapsed or refractory neuroblastoma
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Cheung, N. K. V.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save